09.08.2012 • Topics

Wiley: Publisher for the Olympic Games

London 2012 Olympic and Paralympic Games: The Official Commemorative Book and...
"London 2012 Olympic and Paralympic Games: The Official Commemorative Book" and "Making History at London 2012" will be published in October 2012

Millions of people around the world have been drawn into the excitement of the Olympic Games, cheering on their home teams and marveling at the athleticism and accomplishments of the participants. In 2010, Wiley achieved the distinction of being the first company in history to publish all the official books for the Olympic Games, a portfolio of commemorative publications and visitor guides for the Winter Games and Paralympic Winter Games in Vancouver, Canada. In 2012, Wiley is playing an even more important role as the official publisher of nine books for the London Games, including the official commemorative book.

The Olympic rings are one of the world's most powerful brands, and the London Games, touted as the first social media Olympics, will extend the brand as never before. Wiley's association with London 2012 is an extraordinary opportunity to showcase expertise in publishing high-quality, visually stunning print and digital books while reaching a vast new audience beyond traditional markets. The nine books comprising the program target the middle to high-end market, with high production values, compelling layouts, and copious illustrations.

Watch this online exhibit to see all of Wiley's London 2012 publications, including the all-important official commemorative book.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read